Skip to main content
Year archive

MESOBLAST LTD — 2022 filings

All 135 regulatory filings released by MESOBLAST LTD (MESO) in 2022, sourced directly from the official regulator.

135 Filings
2022 Period
2022 filings (135)
Filing Released Lang
PROSPECTUS
Prospectus
2022-12-30 English
6-K
Foreign Filer Report
2022-12-29 English
Regulatory Filings 2022
Regulatory Filings
2022-12-29 English
Regulatory Filings 2022
Regulatory Filings
2022-12-28 English
PROSPECTUS
Prospectus
2022-12-27 English
Regulatory Filings 2022
Regulatory Filings
2022-12-23 English
Proposed issue of securities - MSB 5 pages 28.8KB
Regulatory Filings
2022-12-22 English
Extension of Undrawn US$30 million Facility 2 pages 160.1KB
Regulatory Filings
2022-12-22 English
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8
Regulatory Filings
2022-12-20 English
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8
Regulatory Filings
2022-12-20 English
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8
Regulatory Filings
2022-12-20 English
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8
Regulatory Filings
2022-12-20 English
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8
Regulatory Filings
2022-12-20 English
REGISTRATION STATEMENT
Regulatory Filings
2022-12-20 English
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-3
Regulatory Filings
2022-12-20 English
6-K
Foreign Filer Report
2022-12-07 English
Appendix 3G, Appendix 3H and Appendix 3Y 25 pages 599.8KB
Regulatory Filings
2022-12-01 English
6-K
Foreign Filer Report
2022-11-28 English
6-K
Foreign Filer Report
2022-11-28 English
Amended Constitution 51 pages 632.0KB
Regulatory Filings
2022-11-23 English
First Quarter Financial Results on Form 6-K 85 pages 515.8KB
Regulatory Filings
2022-11-22 English
CEO First Quarter Results and 2022 AGM Presentation 29 pages 2.0MB
Regulatory Filings
2022-11-22 English
MSB Q1 Financial Results and Operational Highlights 8 pages 452.6KB
Regulatory Filings
2022-11-22 English
Long-Term Survival for Acute GvHD Treatment with Remestemcel 3 pages 199.0KB
Regulatory Filings
2022-11-22 English
Chairman's Address to Shareholders 3 pages 189.3KB
Regulatory Filings
2022-11-22 English
Results of Meeting 3 pages 187.2KB
Regulatory Filings
2022-11-22 English
Mesoblast First Quarter Financial Results Webcast 1
Regulatory Filings
2022-11-20 English
6-K
Foreign Filer Report
2022-11-16 English
Removal of Amendment to Constitution About Virtual Meetings 2 pages 130.6KB
Regulatory Filings
2022-11-14 English
6-K
Foreign Filer Report
2022-11-07 English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 395.9KB
Regulatory Filings
2022-10-30 English
Appendix 4G and Corporate Governance Statement 22 pages 382.8KB
Regulatory Filings
2022-10-23 English
Annual Report to Shareholders 240 pages 6.9MB
Regulatory Filings
2022-10-23 English
Notice of Annual General Meeting and Proxy Form 30 pages 437.9KB
Regulatory Filings
2022-10-23 English
6-K
Foreign Filer Report
2022-10-22 English
Notification of cessation of securities - MSB 4 pages 24.3KB
Regulatory Filings
2022-10-13 English
6-K
Foreign Filer Report
2022-10-05 English
Submits New Information to FDA IND File for SR-aGVHD 3 pages 167.0KB
Regulatory Filings
2022-10-02 English
REGISTRATION STATEMENT
Registration Form
2022-09-30 English
6-K
Foreign Filer Report
2022-09-23 English
Change of Director's Interest Notice 2 pages 223.8KB
Regulatory Filings
2022-09-19 English
6-K
Foreign Filer Report
2022-09-14 English
Regulatory Filings 2022
Regulatory Filings
2022-09-13 English
Change of Director's Interest Notice 2 pages 221.3KB
Regulatory Filings
2022-09-11 English
Regulatory Filings 2022
Regulatory Filings
2022-09-08 English
Regulatory Filings 2022
Regulatory Filings
2022-09-07 English
AMENDMENT NO. 8
Major Shareholding Notification
2022-09-06 English
REGISTRATION STATEMENT
Regulatory Filings
2022-08-31 English
6-K
Foreign Filer Report
2022-08-31 English
20-F
Annual Report FY 2022
2022-08-31 English
Preliminary Final Report 239 pages 3.3MB
Regulatory Filings
2022-08-30 English
Annual Financial Results Presentation 27 pages 1.8MB
Regulatory Filings
2022-08-30 English
MSB Annual Financial Results and Operational Highlights 8 pages 338.3KB
Regulatory Filings
2022-08-30 English
Mesoblast 2022 Full Year Financial Results Webcast 1
Regulatory Filings
2022-08-29 English
6-K
Foreign Filer Report
2022-08-20 English
Final Director's Interest Notice 2 pages 229.7KB
Regulatory Filings
2022-08-17 English
Initial Director's Interest Notice 2 pages 314.6KB
Regulatory Filings
2022-08-17 English
Director Appointment 2 pages 141.4KB
Regulatory Filings
2022-08-17 English
6-K
Foreign Filer Report
2022-08-16 English
Change in substantial holding 6 pages 501.9KB
Regulatory Filings
2022-08-15 English
Ceasing to be a substantial holder from TOP 8 pages 330.5KB
Regulatory Filings
2022-08-15 English
Ceasing to be a substantial holder from TEK 8 pages 334.9KB
Regulatory Filings
2022-08-15 English
Ceasing to be a substantial holder - Tiga Trading Pty Ltd 8 pages 316.1KB
Regulatory Filings
2022-08-15 English
Appendix 2A 22 pages 327.8KB
Regulatory Filings
2022-08-11 English
Cleansing Notice 1 page 176.9KB
Regulatory Filings
2022-08-11 English
Reinstatement to Quotation 1 page 89.0KB
Regulatory Filings
2022-08-08 English
US$45 Million Private Placement to Major Shareholders 2 pages 164.9KB
Regulatory Filings
2022-08-08 English
Appendix 3B 57 pages 677.0KB
Regulatory Filings
2022-08-08 English
Voluntary Suspension 3 pages 229.0KB
Regulatory Filings
2022-08-07 English
6-K
Foreign Filer Report
2022-08-05 English
Pause in Trading 1 page 111.3KB
Regulatory Filings
2022-08-03 English
Trading Halt 2 pages 213.2KB
Regulatory Filings
2022-08-03 English
Quarterly Activities/Appendix 4C Cash Flow Report 12 pages 419.7KB
Regulatory Filings
2022-07-28 English
6-K
Foreign Filer Report
2022-07-21 English
Rexlemestrocel-L Improves LVEF, Preceding Reduction in MACE 4 pages 182.8KB
Regulatory Filings
2022-07-18 English
6-K
Foreign Filer Report
2022-07-14 English
Appendix 3H and Appendix 3Y 6 pages 360.3KB
Regulatory Filings
2022-07-13 English
Rexlemestrocel-L to be Highlighted on Heart Failure Panel 3 pages 164.6KB
Regulatory Filings
2022-07-11 English
Chronic Low Back Pain KOL Event Presentation 30 pages 7.2MB
Regulatory Filings
2022-06-20 English
Mesoblast CLBP Event with Key Opinion Leaders 3 pages 165.8KB
Regulatory Filings
2022-06-20 English
6-K
Foreign Filer Report
2022-06-17 English
Litigation Update 2 pages 171.1KB
Regulatory Filings
2022-06-13 English
Mesoblast to Host KOL Event on Chronic Low Back Pain 3 pages 166.7KB
Regulatory Filings
2022-06-08 English
6-K
Foreign Filer Report
2022-06-03 English
6-K
Foreign Filer Report
2022-06-03 English
Third Quarter Financial Results on Form 6-K 96 pages 596.2KB
Regulatory Filings
2022-05-31 English
MSB Q3 Financial Results and Operational Highlights 9 pages 348.0KB
Regulatory Filings
2022-05-31 English
Third Quarter Results Presentation 44 pages 2.8MB
Regulatory Filings
2022-05-31 English
Remestemcel-L Survival Outcomes in COVID-19 ARDS Patients 2 pages 177.4KB
Regulatory Filings
2022-05-30 English
Mesoblast Q3 Financial Results Webcast 1 page 112.5
Regulatory Filings
2022-05-30 English
Ceasing to be a substantial holder 23 pages 1.1MB
Regulatory Filings
2022-05-29 English
6-K
Foreign Filer Report
2022-05-23 English
Becoming a substantial holder 31 pages 1.3MB
Regulatory Filings
2022-05-19 English
Litigation Update 2 pages 172.0KB
Regulatory Filings
2022-05-18 English
6-K
Foreign Filer Report
2022-05-03 English
Ceasing to be a substantial holder 21 pages 1.1MB
Regulatory Filings
2022-05-02 English
Ceasing to be a substantial holder 10 pages 142.7KB
Regulatory Filings
2022-05-01 English
Quarterly Activities/Appendix 4C Cash Flow Report 12 pages 419.1KB
Regulatory Filings
2022-04-28 English
6-K
Foreign Filer Report
2022-04-20 English
Becoming a substantial holder 29 pages 1.3MB
Regulatory Filings
2022-04-18 English
Appendix 3G and Appendix 3H 21 pages 399.3KB
Regulatory Filings
2022-04-13 English
6-K
Foreign Filer Report
2022-04-11 English
MESOBLAST LIMITED
Major Shareholding Notification
2022-04-08 English
Company Secretary Appointment 1 page 138.2KB
Regulatory Filings
2022-04-05 English
6-K
Foreign Filer Report
2022-03-30 English
Becoming a substantial holder 36 pages 336.0KB
Regulatory Filings
2022-03-28 English
Initial Director's Interest Notice 2 pages 188.6KB
Regulatory Filings
2022-03-27 English
Director Appointment 2 pages 174.7KB
Regulatory Filings
2022-03-23 English
6-K
Foreign Filer Report
2022-03-01 English
6-K
Foreign Filer Report
2022-02-26 English
6-K
Foreign Filer Report
2022-02-25 English
Half Yearly Report and Accounts 104 pages 950.4KB
Regulatory Filings
2022-02-24 English
Second Quarter Results Presentation 42 pages 2.8MB
Regulatory Filings
2022-02-24 English
MSB Q2 Financial Results and Operational Highlights 12 pages 591.0KB
Regulatory Filings
2022-02-24 English
Final Director's Interest Notice 2 pages 184.8KB
Regulatory Filings
2022-02-24 English
Mesoblast Q2 Financial Results Webcast 1 page 111.9
Regulatory Filings
2022-02-23 English
6-K
Foreign Filer Report
2022-02-22 English
Ulcerative Colitis & Crohns Results Presented at ECCO 4 pages 187.5KB
Regulatory Filings
2022-02-20 English
6-K
Foreign Filer Report
2022-02-04 English
Mesoblast Appoints Dr Eric Rose as Chief Medical Officer 4 pages 203.6KB
Regulatory Filings
2022-02-01 English
6-K
Foreign Filer Report
2022-02-01 English
Appendix 4C Quarterly Activity Report 10 pages 351.5KB
Regulatory Filings
2022-01-30 English
6-K
Foreign Filer Report
2022-01-28 English
MSB Presents at Edison Group Global Healthcare Conference 2 pages 154.9KB
Regulatory Filings
2022-01-24 English
AUTOMATIC SHELF REGISTRATION STATEMENT
Regulatory Filings
2022-01-24 English
6-K
Foreign Filer Report
2022-01-21 English
MESOBLAST LIMITED
Major Shareholding Notification
2022-01-19 English
6-K
Foreign Filer Report
2022-01-19 English
Proposed issue of securities - MSB 6 pages 29.4KB
Regulatory Filings
2022-01-17 English
Cleansing Notice and Appendix 2A 21 pages 503.9KB
Regulatory Filings
2022-01-17 English
Appendix 3G, Appendix 3H and Appendix 3Y 24 pages 560.2KB
Regulatory Filings
2022-01-16 English
Biotech Showcase 2022 Presentation 36 pages 3.5MB
Regulatory Filings
2022-01-11 English
36-Month Results of Phase 3 Trial in Chronic Low Back Pain 2 pages 165.4KB
Regulatory Filings
2022-01-11 English
Prospectus for Warrants Related to Oaktree Debt Refinance 45 pages 606.6KB
Regulatory Filings
2022-01-05 English
6-K
Foreign Filer Report
2022-01-03 English